This HTML5 document contains 76 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dbpedia-dehttp://de.dbpedia.org/resource/
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n13https://global.dbpedia.org/id/
yagohttp://dbpedia.org/class/yago/
dbthttp://dbpedia.org/resource/Template:
schemahttp://schema.org/
n14http://dbpedia.org/resource/List_of_drugs:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n18http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
freebasehttp://rdf.freebase.com/ns/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbchttp://dbpedia.org/resource/Category:
dbphttp://dbpedia.org/property/
n11http://www.medigene.com/
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Verband_Forschender_Arzneimittelhersteller
dbo:wikiPageWikiLink
dbr:MediGene
Subject Item
dbr:Cornelis_Melief
dbo:wikiPageWikiLink
dbr:MediGene
Subject Item
dbr:MediGene
rdf:type
wikidata:Q43229 wikidata:Q4830453 yago:Organization108008335 dbo:Company owl:Thing yago:WikicatBiotechnologyCompanies dbo:Organisation yago:WikicatCompaniesEstablishedIn1994 yago:Institution108053576 yago:Group100031264 yago:Abstraction100002137 yago:Company108058098 yago:YagoLegalActor yago:YagoLegalActorGeo wikidata:Q24229398 yago:YagoPermanentlyLocatedEntity yago:SocialGroup107950920 n18:Agent n18:SocialPerson dbo:Agent yago:WikicatBiotechnologyCompaniesOfGermany schema:Organization
rdfs:label
Medigene MediGene
rdfs:comment
Die Medigene AG ist ein an der Frankfurter Wertpapierbörse notiertes Biotechnologie-Unternehmen mit Hauptsitz in Martinsried bei München. Das Unternehmen entwickelt Immuntherapien zur Steigerung der T-Zell-Aktivität gegen solide Krebserkrankungen. Erste Produktkandidaten befinden sich in der klinischen Entwicklung. Die Aktien der Medigene sind im Prime Standard der Deutschen Börse notiert. Medigene AG (FSE: MDG1, ISIN DE000A1X3W00, Prime Standard) is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development.
foaf:name
Medigene AG
foaf:homepage
n11:
dbp:name
Medigene AG
dbo:location
dbr:Germany dbr:Martinsried
dcterms:subject
dbc:1994_establishments_in_Germany dbc:Pharmaceutical_companies_established_in_1994 dbc:Biotechnology_companies_established_in_1994 dbc:Biotechnology_companies_of_Germany
dbo:wikiPageID
21969655
dbo:wikiPageRevisionID
1025379859
dbo:wikiPageWikiLink
dbc:Biotechnology_companies_established_in_1994 dbc:Pharmaceutical_companies_established_in_1994 dbc:1994_establishments_in_Germany dbr:Germany dbr:Martinsried dbr:Biotechnology dbc:Biotechnology_companies_of_Germany
dbo:wikiPageExternalLink
n11:
owl:sameAs
n13:RFTR wikidata:Q1403929 yago-res:MediGene freebase:m.05p42gp dbpedia-de:Medigene
dbp:wikiPageUsesTemplate
dbt:Authority_control dbt:Unreferenced dbt:Germany-company-stub dbt:Portal dbt:Infobox_company
dbp:foundation
1994
dbp:homepage
n11:
dbp:industry
dbr:Biotechnology
dbp:keyPeople
Prof Dolores J Schendel , Gerd Zettlmeissl
dbp:location
dbr:Germany dbr:Martinsried
dbp:tradedAs
MDG1
dbp:type
Stock company
dbo:abstract
Medigene AG (FSE: MDG1, ISIN DE000A1X3W00, Prime Standard) is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Die Medigene AG ist ein an der Frankfurter Wertpapierbörse notiertes Biotechnologie-Unternehmen mit Hauptsitz in Martinsried bei München. Das Unternehmen entwickelt Immuntherapien zur Steigerung der T-Zell-Aktivität gegen solide Krebserkrankungen. Erste Produktkandidaten befinden sich in der klinischen Entwicklung. Die Aktien der Medigene sind im Prime Standard der Deutschen Börse notiert.
prov:wasDerivedFrom
wikipedia-en:MediGene?oldid=1025379859&ns=0
dbo:wikiPageLength
1244
dbo:foundingYear
1994-01-01
dbo:industry
dbr:Biotechnology
foaf:isPrimaryTopicOf
wikipedia-en:MediGene
Subject Item
dbr:Etomoxir
dbo:wikiPageWikiLink
dbr:MediGene
Subject Item
dbr:Planegg
dbo:wikiPageWikiLink
dbr:MediGene
Subject Item
n14:_V–Ve
dbo:wikiPageWikiLink
dbr:MediGene
Subject Item
wikipedia-en:MediGene
foaf:primaryTopic
dbr:MediGene